Jabre Capital Partners’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,000	Closed	-$2.45M	–	111
2014 Q2	$2.45M	Buy	10,000 +2,000	+25%	+$490K	0.17%	89
2014 Q1	$2.12M	Buy	+8,000	New	+$2.12M	0.2%	77